OFF-LABEL USE OF PEMBROLIZUMAB IN PD-L1 POSITIVE METASTATIC ANAPLASTIC THYROID CARCINOMA: A CASE REPORT

OFF-LABEL USE OF PEMBROLIZUMAB IN PD-L1 POSITIVE METASTATIC ANAPLASTIC THYROID CARCINOMA: A CASE REPORT